• Skip to main content
  • Skip to footer

GBT Pharma

Experts in OTC market access

  • Our Services
    • International Business Development
    • International Product Development
  • Our Products
    • cannaQIX
    • Klear-vol
    • Estroplus Meno Manage
    • Pediatra Suizo
    • Estroplus™
    • Phytovir®
    • Similasan®
    • Kwai
    • Kira
  • About GBT Pharma
    • Company History
  • GBT Pharma Clients
  • The GBT Pharma Team
    • Our Team in Switzerland
    • Our Team in Latin America
    • Our Team in the UK
  • News
  • Contact Us

Heather Scott

March 9, 2020 By Heather Scott

GBT Pharma welcomes Kira brand

Our UK sister company Precision Healthcare is proud to announce the addition of the Kira brand to the portfolio. From helping get back to a good night's …

[Read more...] about GBT Pharma welcomes Kira brand

March 6, 2020 By Heather Scott

GBT Pharma welcomes Kwai to portfolio

Our UK sister company - Precision Healthcare - is proud to announce it has secured an exclusive worldwide license for leading heart health supplement Kwai, …

[Read more...] about GBT Pharma welcomes Kwai to portfolio

May 24, 2018 By Heather Scott

GBT Pharma Acquires Phytovir®

GBT Pharma has acquired Swiss OTC brand Phytovir®, for an undisclosed sum. Specialists in international market access for OTC companies and brands, GBT …

[Read more...] about GBT Pharma Acquires Phytovir®

Next Page »

Footer

Contact Us

Rte de la Vignettaz 25 |

1700 Fribourg |

Switzerland |

Tel: + 41 79 262 60 43

gian.trepp@gbtpharma.com

About Us

We specialize in developing international markets for our clients. As your partner in driving international growth, GBT Pharma works to quickly understand your business and its objectives.

Follow Us

  • LinkedIn

Copyright © 2023 · GBT Pharma